ABBOTT LABORATORIES Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Abbott Laboratories quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2024.
  • Abbott Laboratories Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $1.08B, a 4.19% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

ABBOTT LABORATORIES Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.08B -$47M -4.19% Dec 31, 2024 10-K 2025-02-21
Q4 2023 $1.12B +$6M +0.54% Dec 31, 2023 10-K 2025-02-21
Q4 2022 $1.12B -$37M -3.21% Dec 31, 2022 10-K 2024-02-16
Q4 2021 $1.15B +$52M +4.72% Dec 31, 2021 10-K 2023-02-17
Q4 2020 $1.1B +$167M +17.9% Dec 31, 2020 10-K 2022-02-18
Q4 2019 $934M Dec 31, 2019 10-K 2021-02-19
Q3 2019 $881M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $850M Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $833M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.